Score Overview
Explore the 2021 public Archive ranking →
Where Elevance Health Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- ELV
2012: 13.4% · 2021: 26.0% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 394.59 | — |
1 Year2025-09-26 | $ 312.40 | 26.31% |
5 Years2021-09-28 | $ 358.51 | 10.07% |
10 Years2016-09-28 | $ 110.98 | 255.55% |
20 Years2006-09-28 | $ 60.35 | 6x |
30 Years1996-09-27 | $ 6.30 | 62x |
All Time2001-01-02 | $ 20.99 | 18x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time2001-01-02 |
|---|---|---|---|---|---|---|---|
| Price | $ 394.59 | $ 312.40 | $ 358.51 | $ 110.98 | $ 60.35 | $ 6.30 | $ 20.99 |
| Return | — | 26.31% | 10.07% | 255.55% | 6x | 62x | 18x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 200.41B | $ 5.24B | $ 35.56B |
| 2025 | $ 199.12B | $ 5.66B | $ 9.49B |
| 2024 | $ 176.81B | $ 5.98B | $ 8.28B |
| 2023 | $ 171.34B | $ 5.98B | $ 6.52B |
| 2022 | $ 156.59B | $ 5.89B | $ 7.38B |
| 2021 | $ 138.63B | $ 6.10B | $ 4.88B |
| 2020 | $ 121.86B | $ 4.57B | $ 5.74B |
| 2019 | $ 104.21B | $ 4.80B | $ 4.93B |
| 2018 | $ 92.10B | $ 3.75B | $ 3.93B |
| 2017 | $ 90.03B | $ 3.84B | $ 3.60B |
| 2016 | $ 84.97B | $ 2.46B | $ 4.07B |
| 2015 | $ 79.23B | $ 2.56B | $ 2.11B |
| 2014 | $ 73.92B | $ 2.56B | $ 2.15B |
| 2013 | $ 71.12B | $ 2.65B | $ 1.58B |
| 2012 | $ 61.53B | $ 2.65B | $ 2.47B |
| 2011 | $ 60.80B | $ 2.64B | $ 2.20B |
| 2010 | $ 58.84B | $ 2.88B | $ 1.78B |
| 2009 | $ 61.64B | $ 4.74B | $ 4.81B |
| 2008 | $ 62.45B | $ 2.49B | $ 2.18B |
| 2007 | $ 61.39B | $ 3.34B | $ 2.76B |
| 2006 | $ 57.00B | $ 3.09B | $ 2.60B |
| 2005 | $ 45.15B | $ 2.46B | $ 19.52B |
| 2004 | $ 20.81B | $ 960M | $ 15.04B |
| 2003 | $ 16.75B | $ 774M | $ 7.37B |
| 2002 | $ 13.25B | $ 549M | $ 6.64B |
| IPO2001 | $ 10.44B | $ 342M | $ 4.47B |
Elevance Health Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 79.23B to $ 199.12B and net income grew from $ 2.56B to $ 5.66B. Revenue increased in every one of those 10 years; net income in 4.
Across Elevance Health Inc's full reported history, from 2001 to 2025, revenue grew from $ 10.44B to $ 199.12B and net income grew from $ 342M to $ 5.66B. Revenue increased in 92% of the years measured; net income in 48%.
Elevance Health Inc currently holds a 20-year HDB Score of 5.9 out of 10. How the HDB Score is calculated.
Membership
Continue ELV’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
